Records containing: Neoplasms, Germ Cell and Embryonal
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-13Phase 1 Trial of Engineered HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
-
CLINICAL_TRIALS study record update · 2026-03-05A Phase III, Randomized, Open-Label Study of Pralsetinib Versus Standard of Care for First-Line Treatment of RET Fusion-Positive, Metastatic Non-Small Cell Lung Cancer
-
CLINICAL_TRIALS study record update · 2025-05-31A Phase 1/2 Study of the Highly-selective RET Inhibitor, BLU-667, in Patients With Thyroid Cancer, Non-Small Cell Lung Cancer (NSCLC) and Other Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2025-01-30Olaparib as Salvage Treatment for Cisplatin-resistant Germ Cell Tumor
-
CLINICAL_TRIALS study record update · 2024-11-05The Expanded Access Use of Vorasidenib in Patients With IDH1 or IDH2 Mutated Glioma
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-02-28Secured Access to Pembrolizumab for Patients With Selected Rare Cancer Types
-
CLINICAL_TRIALS study record update · 2023-01-18Investigator-initiated and Open-labeled Clinical Trial for Evaluation of Maximum Tolerated Dose, Safety and Efficiency of MSC11FCD Therapy to Recurrent Glioblastoma Patients
-
CLINICAL_TRIALS study record update · 2022-12-23SEPTRALU, Spanish Series of Patients Treated With the Radionuclide Lutetium177
-
CLINICAL_TRIALS study record update · 2022-04-05Phase I/II Evaluation of Continuous 24h Intravenous Infusion of Mithramycin, an Inhibitor of Cancer Stem Cell Signaling, in Patients With Primary Thoracic Malignancies or Carcinomas, Sarcomas or Germ Cell Neoplasms With Pleuropulmonary Metastases
-
CLINICAL_TRIALS study record update · 2021-12-27Multicenter Database of Patients With Germ Cell Tumor in Order to Characterize Clinicopathologically and to Evaluate Cancer Treatment Outcomes
-
CLINICAL_TRIALS study record update · 2021-08-10An External Control, Observational, Retrospective Study Assessing the Effect of Pralsetinib Compared With Best Available Therapy for Patients With RET-Fusion Positive Advanced Non-Small Cell Lung Cancer
-
CLINICAL_TRIALS study record update · 2019-03-05Phase II Study of Avelumab in Multiple Relapsed/Refractory Testicular Germ Cell Cancer.
-
CLINICAL_TRIALS study record update · 2018-08-08Understanding the Molecular and Genetic Differences Between GCT at the Time of the Initial Diagnosis and at Late Relapse
-
CLINICAL_TRIALS study record update · 2018-07-05Phase I Evaluation of Adjuvant Oral Decitabine and Tetrahydrouridine With or Without Celecoxib in Patients Undergoing Pulmonary Metastasectomy
-
CLINICAL_TRIALS study record update · 2015-01-29Phase II Study of Oxaliplatin Plus Bevacizumab Salvage Chemotherapy in Patients With Germ Cell Tumors
-
CLINICAL_TRIALS study record update · 2008-02-11Phase II Study of Combined Oxaliplatin and Paclitaxel for Metastatic Germ Cell Tumors